118 DEVELOPMENT AND EVALUATION OF A TIME-RESOLVED FLUORESCENCE IMMUNOASSAY FOR ESTRONE-1-SULFATE IN URINE AS A TOOL FOR DIAGNOSIS OF EARLY PREGNANCY IN SWINE

2008 ◽  
Vol 20 (1) ◽  
pp. 139
Author(s):  
Y. S. Park ◽  
S. H. Yang ◽  
S. M. Park ◽  
S. J. Kim ◽  
J. B. Kim

Early identification of pregnancy or non-pregnancy in sows is considered very important, as the management of sows during the post service period is crucial if the breeding efficiency of a herd is to be maximized. Studies of steroid hormones in pregnant sows showed that there was a significant increase in plasma estrone-1-sulfate concentration by the 16th day of gestation, which reaches peak values between Days 23 and 30 of gestation. Since plasma estrone-1-sulfate concentrations are high between Days 23 and 30 of pregnancy, its determination has been used as a means for early pregnancy diagnosis and monitoring fertility in sows. However, the application of the method in pig farms on a routine basis remains restricted because blood sampling is difficult and disturbs the animals. The present study describes the development of a simple and reliable time-resolved fluorescence immunoassay (TR-FIA) method for the estimation of estrone-1-sulfate in swine urine, which was assessed as a means for early diagnosis of pregnancy and monitoring fertility in sows. We demonstrated cross activity between Anti-estrone-1-glucuronide antibody (Clone 155) and estrone-1-sulfate. The method is based on a direct competitive heterogeneous immunoassay by the typical procedure of competitive immunocomplex formation. For detection of estrone-1-sulfate, anti-estrone-1-glucuronide antibody (Clone 155) was first coated on polystyrene microplates, and estrone-1-sulfate was captured by the primary antibody with estrone-1-glucuronide labeled with europium. The immunocomplex was subsequently dissociated by the enhancement solution containing Triton X-100, acetic acid, and chelators. The free europium was detection by DELFIA 1420 detector (Perkin-Elmer Life Sciences, Waltham, MA, USA). The fluorescence intensity of free europium at 613 nm was proportional to the logarithm of the concentration of estron-1-sulfate in a dynamic range of 0.078~10 ng mL–1. Intra-assay variation for estrone-1-sulfate was 4%. The limit of quantification was 100 pg mL–1. The mean estrone-1-sulfate concentration was significantly higher in pregnant sows (15.6 � 5.3 ng mL–1) than in non-pregnant sows and in sows in estrus (0.74 � 0.44 ng mL–1). Taking the concentration of 20 pg mL–1 as a cut-off, all cases of non-pregnant sows and sows in estrus were negative. Urine estrone-1-sulfate concentrations in pregnant sows at 23-day intervals post-service were 14~16 ng mL–1. According to the results of our field trial, urine estrone-1-sulfate concentrations are very low during estrus and remain low in non-pregnant sows at different stages of the estrous cycle, whereas the concentration increases significantly during specific stages of pregnancy at 23-day intervals. It is concluded that the satisfactory sensitivity of the present assay in combination with the good correlation for pregnancy from the present field trial makes this method a very useful technique for early pregnancy diagnosis in swine; the simplicity of urine sampling makes also it suitable for practical use.

1992 ◽  
Vol 38 (5) ◽  
pp. 725-730 ◽  
Author(s):  
S E Kakabakos ◽  
M J Khosravi

Abstract We developed a direct competitive-type immunoassay for progesterone in serum that combines the advantages of the biotin-streptavidin system with the antibody-immunobilization approach. We synthesized biotinylated progesterone derivatives of five different proteins and, after initial evaluation of the conjugates, selected biotinylated bovine IgG-progesterone as the most suitable tracer. Progesterone released from binding proteins with danazol competes with the biotinylated tracer conjugate for binding to a limited amount of a mouse anti-progesterone monoclonal antibody in microtitration wells coated with a goat anti-mouse IgG antibody. The binding of the biotinylated tracer is then monitored by reaction with a streptavidin-based universal detection reagent developed for time-resolved fluorometry. The assay demonstrated typical performance characteristics with respect to the dynamic range, detection limit, and precision. Recovery averaged 99.3% (SD 8.3%) and dilution experiments showed good linearity. Measurements correlated well with those from three commercially available direct immunoassays for progesterone.


2016 ◽  
Vol 22 (2) ◽  
pp. 130-135 ◽  
Author(s):  
Ling Wang ◽  
Mujuan Xu ◽  
Ruolan Huang ◽  
Xiao Chang ◽  
Cuicui Chen ◽  
...  

The aim of this study was to establish a dual-label time-resolved fluorescence immunoassay (TRFIA) for the simultaneous determination of cardiac troponin T (cTnT) and myoglobin (MYO) for the early diagnosis of acute myocardial infarction. The sandwich immunoassay was used to detect the concentration of cTnT and MYO in serum. cTnT and MYO in serum were captured by anti-cTnT and anti-MYO antibodies immobilized on microtiter wells and then banded together with another anti-cTnT and anti-MYO labeled with europium(III) Sm3+ and samarium(III) Eu3+ chelates, followed by fluorescence measurement using time-resolved fluorometry. The performance of this TRFIA was evaluated using the clinical serum and compared with the commercial assays. The linear correlation coefficients ( R2) of the cTnT and MYO standard curves were 0.9993 and 0.9995, respectively. The sensitivity for cTnT detection was 2.21 pg/mL (linear dynamic range was 3.24–963.71 pg/mL), and the average recovery was 100.57%. The sensitivity for MYO detection was 3.24 ng/mL (linear dynamic range was 4.95–976.85 ng/mL), and the average recovery was 99.79%. High correlation coefficients ( R2) were obtained between the commercial assays and dual-label TRFIA ( R2 = 0.999). The present dual-label TRFIA has high sensitivity, specificity, and accuracy in clinical sample analysis. It is a good alternative to the single-label diagnostic methods.


Endocrinology ◽  
2013 ◽  
Vol 154 (5) ◽  
pp. 1934-1939 ◽  
Author(s):  
Farah T. van Genderen ◽  
Frans K. Gorus ◽  
Daniel G. Pipeleers ◽  
Christiaan F. H. van Schravendijk

Abstract The limitations of current rat C-peptide assays led us to develop a time-resolved fluorescence immunoassay for measurements in plasma, incubation media, and tissue/cell extracts. The assay uses 2 monoclonal antibodies, binding to different parts of the C-peptide molecule, and allowing, respectively, capture of the peptide and its detection by europium-labeled streptavidin. It is performed on 25-μL samples for a dynamic range from 66pM up to 3900pM C-peptide and displays over 95% recovery of added peptide in the range of 111pM to 2786pM. Its inter- and intra-assay coefficients of variations are, respectively, lower than 7.6% and 4.8%. Cross-reactivities by rat insulin and by human and porcine C-peptide are negligible, and cross-reactivity by mouse C-peptide is 6% ± 2%. The assay has been validated for in vivo and in vitro measurements of C-peptide release and cellular content. Release patterns were similar to those for insulin and occurred in equimolar concentrations for both peptides. The molar C-peptide contents in purified β-cells and isolated islets were similar to the corresponding insulin contents. This was also the case for pancreatic extracts containing protease inhibitors.


2021 ◽  
Vol 2021 ◽  
pp. 1-8
Author(s):  
Wei Wang ◽  
Jingneng Wang ◽  
Min Wang ◽  
Juan Shen

Immunochromatographic assays are good analytical tools for the detection of drug residues. We report a nanosphere-based time-resolved fluorescence immunoassay (nano-TRFIA) based on a monoclonal antibody and a portable TRFIA analyzer for the rapid quantification of chlorpromazine (CPZ) residues in pork. Under optimal conditions, the nano-TRFIA detected CPZ residues within 6 min of sample pretreatment. The results showed good linearity (R2 = 0.991), with a limit of detection (LOD) of 0.32 μg/kg, a wide dynamic range of 0.46–10.0 μg/kg, and coefficients of variation (CVs) of the overall intrabatch and interbatch assays of 7.34% and 7.65%, respectively. The nano-TRFIA was also used to detect CPZ at different spiked concentrations in pork, and the results were confirmed via ultraperformance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS). The nano-TRFIA was evaluated for the analysis of six commercial pork samples, and the results agreed well with those obtained via UPLC-MS/MS, without significant differences ( P > 0.05 ). Therefore, the proposed nano-TRFIA is a powerful alternative for the rapid and accurate quantification of CPZ residues in pork to meet the required Chinese maximum residue limits for veterinary drugs in foods.


2021 ◽  
pp. 113179
Author(s):  
Shaoxiong Zheng ◽  
Renjing Hu ◽  
Xiaomei Yu ◽  
Lingli Chen ◽  
BinrongWang ◽  
...  

2021 ◽  
Author(s):  
Xindong Chen ◽  
Jianfeng Hong ◽  
Han Zhao ◽  
Zhongyi Xiang ◽  
Yuan Qin ◽  
...  

Abstract Background: A rapid and highly sensitive assay for tumor-associated trypsinogen-2 (TAT-2) based on the time-resolved fluorescence immunoassay (TRFIA) detection technique was developed for the determination of serum TAT-2 levels in cancers. Results: The measurement range of TAT-2-TRFIA was 1.53-300 ng/mL. The within-run and between-run coefficients of variation of TAT-2-TRFIA were 4.38% and 7.82%, respectively. The recovery rate of TAT-2-TRFIA was 103.0%. The cross-reaction rates of trypsin and T-cell immunoglobulin mucin 3 were 0.02% and 0.82%, respectively. The TAT-2-positive rates in lung cancer, liver cancer, nasopharyngeal cancer, cholangiocarcinoma, brain cancer, and pancreatic cancer were 45.9%, 50.0%, 45.0%, 64.3%, 50.0%, and 41.7%, respectively, with the areas under ROC curves of 0.788, 0.734, 0.862, 0.720, 0.887, and 0.585, respectively. In patients with lung cancer, the positive rate of the single indicator CEA was 28.4%, which increased to 60.6% after combined use with TAT-2. In patients with cholangiocarcinoma, the positive rate of CA-199 was 35.7%, which increased to 71.4% after combined use with TAT-2. Conclusions: TAT-2 is expected to be used as an auxiliary diagnostic indicator for the combined use of tumor markers to improve the positive rate and accuracy of detection.


Sign in / Sign up

Export Citation Format

Share Document